Todd Tuschla
Vice President of Investor Relations
Replay available
Neurocrine Biosciences, Inc. (NBIX) Q2 2025 Earnings Call
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) Q2 2025 earnings conference call, held 2025-07-30. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Kyle Gano
Chief Executive Officer
Matt Abernathy
Chief Financial Officer
Eric Benovitch
Chief Commercial Officer
Dr. Sanjay Keswani
Chief Medical Officer
Ivy Roberts
Strategic Advisor & Former Chief Medical Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Neurocrine Biosciences, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.000 -- 00:00:05.220 Good day everyone and welcome to today's NeuroKrin Biosciences Second Quarter 2025 00:00:05.220 -- 00:00:10.700 Results Conference. At this time all participants are in a listen-only mode. 00:00:10.700 -- 00:00:15.640 Later you will have the opportunity to ask questions during the question and answer session. 00:00:15.640 -- 00:00:21.600 You may register to ask a question at any time by pressing star 1 on your telephone keypad. 00:00:21.600 -- 00:00:25.280 You may withdraw yourself from the queue by pressing star 2. 00:00:25.280 -- 00:00:29.120 Please note this call may be recorded and I will be standing by if you should need any 00:00:29.120 -- 00:00:30.900 assistance. 00:00:30.900 -- 00:00:35.920 It is now my pleasure to turn the conference over to Vice President of Investor Relations, 00:00:35.920 -- 00:00:39.280 Todd Tuschla. Please go ahead sir. 00:00:39.280 -- 00:00:43.700 Thank you and happy Wednesday everyone. Welcome to NeuroKrin Biosciences Second Quarter 00:00:43.700 -- 00:00:48.780 2025 Earnings Call. With me today are Kyle Gano, Chief Executive Officer, 00:00:48.780 -- 00:00:53.240 Matt Abernathy, Chief Financial Officer, Eric Benovitch, Chief Commercial Officer, Ivy 00:00:53.240 -- 00:00:58.400 Roberts, and for one first time as Chief Medical Officer Sanjay Keswani. 00:00:58.400 -- 00:01:01.240 During today's call we will be making forward-looking statements. 00:01:01.240 -- 00:01:04.700 These statements are subject to certain risks and uncertainties and our actual results 00:01:04.700 -- 00:01:09.280 may differ materially. I encourage you to review the risk factors discussed in our latest 00:01:09.280 -- 00:01:13.200 SEC filings. After prepared remarks we will jump into Q&A. 00:01:13.200 -- 00:01:16.280 I now turn th...